Chapter 13 Autonomic & Cardiac Pharmacology Flashcards

1
Q

naturally occurring catecholamines

A

epinephrine, norepinephrine, dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

synthetic catecholamines

A

ephedrine, phenylephrine, dobutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

use these drugs in a variety of situations like

A
  • anesthesia-induced hypotension
  • bradycardia
  • anaphylaxis
  • heart failure
  • cardiac resucitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

inotropic

A

force of contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

chronotropic

A

heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

dromotropic

A

conduction velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

beneficial effects of beta stimulation

A
  • bronchodilation
  • vasodilation
  • stabilization of mast cells –> decrease in histamine release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

beneficial effects of alpha stimulation

A

decrease in bronchial secretion

net effect is a decrease in airway resistance with an improvement on oxygenation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

low dose epi is how much and what does it do?

A
  • 10mcg/min
  • peripheral vasculature promotes the redistribution of blood flow to skeletal muscle producing a decrease in SVR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what happens as the dose of epi increases?

A

the alpha effect predominates resulting in vasoconstriction and an increase in SVR

SBP increases while DBP remains unchanged –> increase in PP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

increased alpha effect that occurs with epi also results in

A

renal and splanchnic vasoconstriction

renal blood flow decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MECHANISM 1
interference with synthesis of transmitter: cholinergic system

A
  • choline acetyltransferase inhibitors
  • minimal depletion of Ach
  • sympatholytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MECHANISM 1
interference with synthesis of transmitter: adrenergic system

A
  • ⍺- methyl tyrosine (inhibition of tyrosine hydroxylase)
  • depletion of NE
  • sympatholytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MECHANISM 2
metabolic transformation by same pathway as precursor of transmitter : adrenergic

A
  • methyldopa
  • displacement of NE by ⍺- methyl- NE, which is an ⍺2 agonist, like clonidine, that reduces sympathetic outflow
  • sympatholytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MECHANISM 3
blockade of transport system at nerve terminal membrane: cholinergic

A
  • hemicholinium
  • block of choline uptake with consequent depletion of ACh
  • sympathomimetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MECHANISM 3
blockade of transport system at nerve terminal membrane: adrenergic

A
  • cocaine, imipramine
  • accumulation of NE at receptors
  • sympathomimetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MECHANISM 4
blockade of transport system at nerve terminal membrane: cholinergic

A
  • vesamicol
  • block of ACh storage
  • sympatholytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MECHANISM 4
blockade of transport system at nerve terminal membrane: adrenergic

A
  • reserpine
  • destruction of NE by mitochondrial MAO, and depletion of adrenergic terminals
  • sympatholytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MECHANISM 5
promotion of exocytosis or displacement of transmitter from axon terminal: cholinergic

A
  • latrotoxins
  • cholinomimetic followed by anticholinergic
  • sympathomimetic
19
Q

MECHANISM 5
promotion of exocytosis or displacement of transmitter from axon terminal: adrenergic

A
  • amphetamine, tyramine
  • adrenomimetic
  • sympathomimetic
20
Q

MECHANISM 6
prevention or release of transmitter: cholinergic

A
  • botulinum toxin
  • anticholinergic
  • sympatholytic
21
Q

MECHANISM 6
prevention or release of transmitter: adrenergic

A
  • clonidine, dexmedetomidine
  • antiadrenergic
  • sympatholytic
22
Q

MECHANISM 7
mimicry of transmitter at postjunctional sites: cholinergic

A
  • Muscarinic –> cholinomimetic –> sympathomimetic
  • nicotinic –> methacholine/bethanachol –> cholinomimetic –> sympathomimetic
23
Q

MECHANISM 7
mimicry of transmitter at postjunctional sites: adrenergic

A

⍺1:
- nicotine/epibatidine
- selective alpha-1 adrenomimetic
- sympathomimetic

⍺2:
- phenylephrine
- adrenomimetic (periphery)
- sympathomimetic

⍺1, ⍺2:
- oxymetazoline
- nonselective adrenomimetic
- sympathomimetic

β1:
- dobutamine
- selective cardiac stimulation
- sympathomimetic

β2:
- terbutaline, albuterol
- selective β2 receptor agonist (selective inhibition of smooth muscle contraction)
- sympathomimetic

β1, β2:
- isoprotenerol
- nonselective β adrenomimetic
- sympathomimetic

24
Q

MECHANISM 8
blockade of postsynaptic receptors: cholienrgic

A
  • muscarinic –> atropine, muscarinic blockade, sympatholytic
  • nicotinic –> d-tubucuraine/atracurium, neuromuscular blockade, sympatholytic
  • nicotinic –> trimethaphan, ganglionic blockade, sympatholytic
25
Q

MECHANISM 8
blockade of postsynaptic receptors: adrenergic

A

⍺1, ⍺2: phenoxybenzamine, nonselective ⍺ blockade (irreversible) –> sympatholytic

⍺1, ⍺2: phentolamine, nonselective ⍺ blockade (reversible) –> sympatholytic

⍺1: prazosin/terazosin/doxazosin, selective alpha1 receptor blockade (reversible) –> sympatholytic

⍺2: yohimbine, selective alpha2 receptor blockade –> sympatholytic

β1, β2: propanolol, nonselective beta-receptor blockade –> sympatholytic

β1: metoprolol/atenolol, selective beta 1 recepetor blockade –> sympatholytic

26
Q

MECHANISM 9
inhibition of enzymatic breakdown of transmitter: cholinergic

A

AChE inhibitors (edrophonium/neostigmine) –> cholinomimetic (muscarinic sites) depolarization blockade (nicotinic sites) –> parasympathomimetic

27
Q

MECHANISM 9
inhibition of enzymatic breakdown of transmitter: adrenergic

A

nonselective MAO inhibitors (pargyline/nialamide), little direct effect on NE or sympathetic response; potentiation of tyramine –> parasympathomimetic

selective MAO-B inhibitor (selegiline), adjunct in Parkinson’s dx –> parasympathomimetic

peripheral COMT inhibitor (entacapone), adjunct in Parkinson’s dx –> parasympathomimetic

peripheral and central COMT inhibitor (tolcapone), adjunct in Parkinson’s dx –> parasympathomimetic

28
Q

MECHANISM 10
interference with the second messenger system: adrenergic

A

PDE 3 inhibitors (milrinone), inotrope –> sympathomimetic

29
Q

the conversion of tyrosine to __ by __ __ is inhibited by increased NE synthesis

A

DOPA; tyrosine hydroxylase

30
Q

where is epinephrine synthesized?

A

adrenal medulla

31
Q

sympathetic effect of:
radial muscle, iris

A

contraction (mydriasis), alpha 1

32
Q

parasympathetic effect of:
sphincter muscle, iris

A

contraction (miosis) M3,M2

33
Q
A
34
Q
A
35
Q
A
36
Q
A
36
Q
A
37
Q
A
38
Q
A
39
Q
A
40
Q
A
40
Q
A
41
Q
A
42
Q
A
43
Q
A